Suchergebnisse - "Sanz, Miguel A"

PubPharm (15)

1

NTAL is associated with treatment outcome, cell proliferation and differentiation in acute promyelocytic leukemia

enthalten in: Scientific reports | 2020

von Thomé, C. | Ferreira, G. | Pereira-Martins, D. | +33

2

All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies

enthalten in: Annals of hematology | 2015

von Sanz, M. | Montesinos, P. | Kim, H. | +27

3

All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies

enthalten in: Annals of hematology | 2015

von Sanz, M. | Montesinos, P. | Kim, H. | +27

4

All-trans retinoic acid with daunorubicin or idarubicin for risk-adapted treatment of acute promyelocytic leukaemia: a matched-pair analysis of the PETHEMA LPA-2005 and IC-APL studies

enthalten in: Annals of hematology | 2015

von Sanz, M. | Montesinos, P. | Kim, H. | +27

5

Prognostic impact of KMT2E transcript levels on outcome of patients with acute promyelocytic leukaemia treated with all-trans retinoic acid and anthracycline-based chemotherapy : an International Consortium on Acute Promyelocytic Leukaemia study

enthalten in: British journal of haematology | 2014

von Lucena-Araujo, A. | Kim, H. | Jacomo, R. | +21

6

Conventional induction and post-remission therapy in APL : have we arrived?

enthalten in: Best practice & research. Clinical haematology | 2014

von Sanz, M. | Iacoboni, G. | Montesinos, P.

7

A scoring system to predict the risk of death during induction with anthracycline plus cytarabine-based chemotherapy in patients with de novo acute myeloid leukemia

enthalten in: Cancer | 2012

von Valcárcel, D. | Montesinos, P. | Sánchez-Ortega, I. | +13

8

Prognostic value of FLT3 mutations in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy

enthalten in: Haematologica | 2011

von Barragán, E. | Montesinos, P. | Camos, M. | +119

9

Clinical significance of CD56 expression in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline-based regimens

enthalten in: Blood | 2011

von Montesinos, P. | Rayón, C. | Vellenga, E. | +123

10

Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients : further improvements in treatment outcome

enthalten in: Blood | 2010

von Sanz, M. | Montesinos, P. | Rayón, C. | +118

CommentIn: Nat Rev Clin Oncol. 2010 Sep;7(9):484. - PMID 20824904